Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

GSK plc (GSK)

London
Currency in GBP
Disclaimer
1,586.50
-3.50(-0.22%)
Real-time Data

GSK Price Commentary

This is a great opportunity for everyone to accumilate / increase their position. Good value over time and dividend.
Have to admit my £13 target for this week was over optimistic. However, good value at under £13 & will surely rise in time. They're in the right business for the current situation but the management will have to get their act together.
im really disappointed with my choice with GSK. bought at 1402.
I'm sure you will get your money back by playing the waiting game. If you look at the 10 yr graph, this tells the story.
Great value pick
Should rise above £13 this week.
If you check prevoius years, its always downgraded January/February + Low guidance for H1 as well. For me this is a buying opportunity. It's just the trend right now, all pharmas are down trending. Got 150 shares at 1280. Long.
Too much debt
Theyre changing the business model to offload debt to a more cash flow positive segment🚀
Hang on, bound to go back up at some point. Must be at the bottom @1250
downgraded to 1150. i guess it has got more to go down.
From which broker?
Deutche Bank
Looks like it wants to go to 1200
+3% today, funny, huh. (:
Check the news, they declare an increase of the dividends. Nice. Getting some shares tomorrow morning. :)
Buy just for dividends
lol the spike 1285 to 1320 after hours. Someone just bought big time...
And btw, they double beat on earnings but they crashed... i know they lowered guidance, but c'mooon... :/
Im looking to buy as well. Everything under 1300 is a strong buy imo.
Took a small ****at 1287....next buy will be 1200 if it does go there
Down 4% today and looks cheap with the prospect of vaccine development.
They have a viable vaccine?
They will have. Often the early models are flawed eg -70 storage of low % effectiveness.Developing an adjuvant looks particularly promising.
Good legacy stock, great for regular dividend, price in the low 1300s is very good for Glaxo
Downgraded today
Back to 1290 most likely
Possible
Glad I got out of this at 1400 with some profits
Anything around 1300p makes this a very cheap share. Plus a 6% dividend for good measure.
Waiting for 1290....
Why is it dropping ?
Less ******than aAstrazeneca, but at current PE / yield seems cheap.
se xy
Company will split in two over next two years.  Business is currently stagnant.  Unloved by the market. Too much uncertainty here.
Late 2021 Vaccine, major bust
Buy. Debt is manageable like Abbvie.
No sucker punch as received by AZN for trying to find a vaccine too quickly. Softly softly catchee monkey approach of GSK will pay.
hi
Although not first past the post with the vaccine, they are bound to jump on the bandwagon as major producers. Should keep going up.
EPS beat, Revenue Miss. Overall good, but whole market is crashing...
I wouldn’t sell at this price its lower than March when FTSE was 4900
Thats ok but Sentiment
One Upgrade today to "Buy". Good entry, long.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.